Finerenone: Evaluating and Understanding this Drug as Treatment

Emily Castle, PharmD, provides an evaluation of the 2022 ADA update in terms of prescribing finerenone to patients with diabetes. She also provides a literature review for why finerenone is now recommended for use, and ways to incorporate this treatment into your practice.

[@hakandemirturk]

Thanks for your presentation

[@kaumudic1116]

nicely explained. 👌🏼👏🏼

[@ahmedahm1]

2:40 more selection and less hyperkalemia